GNI Group - Public Comps and Valuation Multiples

GNI Group Overview

About GNI Group

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Founded

2001

HQ

Employees

349

Website

gnipharma.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $179M

LTM EBITDA $151M

EV

$699M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

GNI Group Financials

As of November 2025, GNI Group reported last 12-month revenue of $179M and EBITDA of $151M.

In the same period, GNI Group achieved $84.2M in LTM net income.

See GNI Group valuation multiples based on analyst estimates

GNI Group P&L

In the most recent fiscal year, GNI Group reported revenue of $151M and EBITDA of $19.9M.

GNI Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See GNI Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$179M	XXX	$151M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$116M	XXX	XXX	XXX
Gross Margin	n/a	XXX	76%	XXX	XXX	XXX
EBITDA	$151M	XXX	$19.9M	XXX	XXX	XXX
EBITDA Margin	84%	XXX	13%	XXX	XXX	XXX
EBIT	$154M	XXX	$9.0M	XXX	XXX	XXX
EBIT Margin	86%	XXX	6%	XXX	XXX	XXX
Net Profit	$84.2M	XXX	$7.0M	XXX	XXX	XXX
Net Margin	47%	XXX	5%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for GNI Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $179M. EBITDA for the last twelve months was $151M. In the most recent fiscal year, GNI Group achieved $151M in revenue and $19.9M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$179M	Analyst estimates available to subscribers	$151M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$116M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	76.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$151M	Analyst estimates available to subscribers	$19.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	84.5% EBITDA margin	Analyst estimates available to subscribers	13.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$154M	Analyst estimates available to subscribers	$9.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	86.1% EBIT margin	Analyst estimates available to subscribers	5.9% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$84.2M	Analyst estimates available to subscribers	$7.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	47.1% net profit margin	Analyst estimates available to subscribers	4.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for GNI Group

This financial data table provides comprehensive performance metrics for GNI Group, a company based in Japan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

GNI Group generated $179M in revenue over the last twelve months.
The company achieved $151M in EBITDA over the last twelve months.
Net income over the last twelve months reached $84.2M.

Fiscal Year Performance

In the most recent fiscal year, GNI Group reported $151M in total revenue.
Fiscal year EBITDA was $19.9M.
The company maintained a gross profit margin of 76.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 13.1%.
Net profit margin reached 4.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for GNI Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

GNI Group Stock Performance

GNI Group has current market cap of JPY 134B (or $862M), and EV of JPY 109B (or $699M).

Market Cap Evolution

GNI Group Stock Data

As of December 3, 2025, GNI Group's stock price is JPY 2418 (or $16).

See GNI Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$699M	$862M	XXX	XXX	XXX	XXX	$1.57

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

GNI Group Valuation Multiples

GNI Group's trades at 4.6x EV/Revenue multiple, and 35.1x EV/EBITDA.

See valuation multiples for GNI Group and 15K+ public comps

GNI Group Financial Valuation Multiples

As of December 3, 2025, GNI Group has market cap of $862M and EV of $699M.

Equity research analysts estimate GNI Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

GNI Group has a P/E ratio of 10.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$862M	XXX	$862M	XXX	XXX	XXX
EV (current)	$699M	XXX	$699M	XXX	XXX	XXX
EV/Revenue	3.9x	XXX	4.6x	XXX	XXX	XXX
EV/EBITDA	4.6x	XXX	35.1x	XXX	XXX	XXX
EV/EBIT	4.5x	XXX	77.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	10.2x	XXX	122.4x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-23.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get GNI Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

GNI Group Margins & Growth Rates

GNI Group's last 12 month revenue growth is 47%

GNI Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

GNI Group's rule of 40 is 102% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

GNI Group's rule of X is 202% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for GNI Group and other 15K+ public comps

GNI Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	47%	XXX	33%	XXX	XXX	XXX
EBITDA Margin	84%	XXX	13%	XXX	XXX	XXX
EBITDA Growth	-69%	XXX	29%	XXX	XXX	XXX
Rule of 40	102%	XXX	60%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	202%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	12%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	70%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial